ArticleCellular oncology (Dordrecht, Netherlands)2018

Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.

Zorica Milošević et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.